期刊文献+

犬瘟热病毒H蛋白基因重组腺病毒的构建及免疫效果评估 被引量:3

Construction and Immune Efficacy of Recombinant Adenovirus Expressing H Gene of Canine Distemper Virus
原文传递
导出
摘要 研究选取犬瘟热病毒H蛋白基因为目的基因,利用反转录聚合酶链式反应(RT-PCR)、酶切、连接等方法构建出重组人5型腺病毒穿梭质粒和骨架质粒,两者共转染293AD细胞并包装出重组腺病毒。通过电镜负染、酶切鉴定、Western blot及一步生长曲线测定等方法进行病毒的生物学特性鉴定,证明犬瘟热病毒H蛋白基因重组腺病毒构建正确。犬分别肌肉接种CDV疫苗毒和重组腺病毒,并检测免疫后第14,28,42,56,70,84d时犬血清中抗CDV中和抗体的变化情况。结果显示,犬免疫重组腺病毒后体内产生的抗CDV平均中和抗体水平高于对照组,滴度最高达2-8。研究表明,正确构建的重组腺病毒具有良好的免疫原性,诱导产生的抗犬瘟热病毒中和抗体达到犬最低免疫保护水平,为进一步研发犬瘟热病毒活载体疫苗提供理论依据。 by reverse transcription polymerase chain reaction (RT-PCR) and the restriction enzyme ctlgesuon ana llgauon, then co-transfected into the 293AD cell lines after Pac I linearization respectively. The biological characterization was determined by the electron microscope and restriction enzyme digestion and western blotting analysis and the one-step growth curve, the results proved that the recombinant human adenovirus type 5 that expressed H gene of CDV was constructed correctly. The anti-CDV antibody titers of the dog serum were detected by using neutralization test after a single intramuscular immunization with CDV vaccine strains or recombinants on days 14, 28, 42, 56, 70, 84. The results showed that average anti-CDV antibody titers (up to 2-8 ) were higher than that of the control group. It implied that the recombinant was constructed correctly and has a good immunogenicity, and it could stimulate an effective level of neutralizing antibodies which reached the lowest level of immune protection against CDV. This work provides a theoretical basis for the research and development of a more efficient distemper live vector vaccine.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2014年第1期64-70,共7页 China Biotechnology
基金 国家公益性行业(农业)科研专项经费资助项目(201203056)
关键词 犬瘟热病毒 H基因 腺病毒 免疫效果 Canine distemper virus Hemagglutinin gene Adenovirus Immune efficacy
  • 相关文献

参考文献14

  • 1Appel M J G, Summers B A. Pathogenicity of morhilliviruses for terrestrial carnivores. Vet Microbial, 1995, 44 : 187-191.
  • 2Silin D, Lyubomska O, Ludlow M, et al. Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol, 2007, 81 (24):13649-13658.
  • 3Kommonen C, Rudhack E, Anttila M, et al. Canine distemper of vaccine origin in European mink, Mustela lutreola-a case report. Vet Microbial, 2003, 92: 289-293.
  • 4Fauquet C M, Mayo M A, Maniloff J, et al. Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier Academic Press, 2005.
  • 5Iwatsuki K, Tokiyoshis S, Hiaryame N, et al. Antigenic differences in the H proteins of canine distemper viruses. Vet Microbiol, 2000, 71 : 281-286.
  • 6Jensen T H, Nielsen L, Aasted B, et al. Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper. Vaccine, 2009, 27 ( 38 ) : 5178-5183.
  • 7Hirama K, Togashi K, Vakasa C, et al. Cytotoxic T-lymphocyte activity specific for Hemgaglatinin (H) protein of canine distemper virus in dogs. Vet Med Sci, 2003, 65 (1) :109-112.
  • 8Nia T, Hildegund CJE. Adenoviruses as vaccine vectors. Molecular Therapy, 2004, 10(4) :616-629.
  • 9Barrett T. Morbillivirus infections, with special emphasis on mnrbilliviruses of carnivores. Vet Microbiol, 1999, 69 ( 1-2 ) : 3- 13.
  • 10Von Messling V, Springfeld C, Devaux P, et al. A ferret model of canine distemper virus virulence and 2003, 77 (23) : 12579-12591.

同被引文献26

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部